SEC EDGARJUN 182 min read$CLS

MIONIS ROBERT sold $26.4M of CLS (indirect holdings)

MIONIS ROBERT (Chief Executive Officer) sold 66,056 indirectly-held shares of CELESTICA INC (CLS) at an average of $400.06 ($394.58–$413.68, $26.43M total) across 17 trades on 2026-06-15 under a Rule 10b5-1 trading plan.

Original reporting

SEC EDGAR · MIONIS ROBERT

Published Jun 18, 2026, 12:53 AM UTC

Analysis

alphai AI DeskAI-generated

Added to alphai Jun 18, 2026, 1:05 AM UTC. Informational, not investment advice.

How this was made

alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.

About alphai AI Desk Scoring methodology Report an issue

alphai market briefInsider activity

Primary signal

$CLS

Neutral

medium confidence

Mentioned

$CLS

Relevance

6/10

alphai data visualization · based on SEC EDGAR

Decision brief

The 30-second read

$CLSNeutralLow

Why it matters

The disclosure provides a concrete, time-stamped insider selling event (66,056 shares; ~$26.4M) that can influence short-term sentiment, though 10b5-1 lowers interpretive value.

Market read

A sizable CEO sale in CLS is newly disclosed, but the pre-arranged nature suggests limited fundamental information content.

What to watch

Traders may over-weight insider sales; without accompanying guidance, contract, or earnings changes, the signal is typically weak.

Relevance 6/10Novelty 6/10Timing: Filed 2026-06-17 for a sale executed 2026-06-15

Background

SEC Form 4 reports an insider transaction by Celestica CEO Mionis Robert, executed as an open-market sale under a Rule 10b5-1 plan.

Company-level read

Ticker impact

AI estimates · verify against primary disclosures

$CLSNeutralMedium confidence

Context

Celestica CEO Mionis Robert sold $26.4M of CLS shares via a Rule 10b5-1 plan, with 66,056 shares sold at ~$394.58–$413.68 on 2026-06-15.

Expected impact

Likely limited/short-lived impact; any reaction should fade unless accompanied by other fundamental news.

Evidence & confidence

Form 4 confirms transaction size and timing, but 10b5-1 reduces signaling value versus discretionary selling.

Market effects

Sector

Minimal; this is company-specific insider activity with no stated sector-wide catalyst.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

Because the sale is under a pre-arranged 10b5-1 plan, it may reflect routine liquidity needs rather than bearish expectations.

Key entities

issuer
Celestica Inc
Subject of the Form 4 insider sale; CEO sold shares totaling ~$26.4M.
insider
Mionis Robert
CEO and officer/director who executed the sale under a pre-arranged 10b5-1 plan.

Read at source ← All news

AUG 29

$CLSMedAI 8/10

The Market and UBS Saw Celestica’s $3 Billion Raise Very Differently. Here’s Who I Think Is Right.

Celestica (CLS) stock gained 57% over the past year, underperforming the S&P Tech Hardware Index. Its valuation reflects strong earnings growth expectations, with a forward P/E of 25.38x. Q2 2026 revenue was $4.70B, up 62% YoY, with raised full-year guidance. Analysts remain positive, with a consensus 'Strong Buy' rating and a mean price target of $464.

yahoo.com3 min

AUG 28

$CLSMed

Canada Trade War: What It Means for Electronics Manufacturing · EMSNow

Canada and the US imposed tariffs on each other's exports, including electronics, with no expiry date. Canadian electronics exports are heavily dependent on the US, making the sector vulnerable. Celestica and other EMS providers may relocate production to mitigate costs. Provincial and federal governments are offering support programs. Investors should watch Q3 earnings for affected companies and the impact of Canada's retaliatory tariffs on September 8.

emsnow.com3 min

AUG 26

$CLSHighAI 9/10

Celestica (CLS) Down 12.4% Since Last Earnings Report: Can It Rebound?

Celestica (CLS) shares fell 12.4% since its last earnings report, despite beating Q2 2026 estimates with $2.54 EPS and $4.70B revenue, driven by strong CCS demand. The company raised its 2026 outlook, projecting $20.5B revenue and $11.30 EPS. Management expects revenue growth to accelerate in 2027.

finance.yahoo.com2 min

AUG 24

$DRIMed

This Darden Analyst Turns Bullish; Here Are Top 4 Upgrades For Monday - Darden Restaurants (NYSE:DRI), Ja

Analysts upgraded four companies: Baird raised Darden (DRI) to Outperform with a $250 target, Wolfe upgraded Janux (JANX) to Outperform with a $23 target, UBS upgraded Celestica (CLS) to Buy with a $430 target, and Wolfe upgraded PulteGroup (PHM) to Outperform with a $129 target. All companies closed at or near their respective targets on Friday.

benzinga.com2 min

AUG 14

$CLSMedAI 8/10

Celestica Stock Falls 2.63%: Why TSX:CLS Is in Focus After AI Infrastructure Boom, $20.5 Billion Revenue Outlook and New 2027 Growth Catalysts

Celestica Inc. (TSX:CLS) shares fell 2.63% on Aug. 14, 2026 despite strong Q2 results and raised outlook. Q2 revenue rose about 62% to US$4.70B and adjusted EPS to US$2.54. 2026 revenue guidance was lifted to about US$20.5B, adjusted EPS to US$11.30, and FCF to US$600M, with 2027 growth expected to accelerate on AI infrastructure demand.

kalkine.ca7 min

AUG 12

$LITEMedAI 8/10

Nokia, Celestica, and Applied Optoelectronics Rally After Lumentum Sparks Broad Optics Rally

After Lumentum’s fiscal Q4 beat, shares of Lumentum Holdings (LITE) rose 14% to $932. Lumentum reported adjusted EPS of $3.23 vs $2.99 and revenue of $1.01B (+109%). Nokia (NOK) and Celestica (CLS) each gained 9%, while Ciena (CIEN) rose 11% and Applied Optoelectronics (AAOI) added 3% in a sector sympathy rally tied to AI optics demand.

finance.yahoo.com7 min